Biobonic Monday, 11/09/20 08:00:00 PM Re: None Post # of 500 From the recent quarterly filing Quote:On July 15, 2020, an employee of the Company filed a Complaint alleging unequal pay based on gender and other employment based claims. The Company intends to defend the lawsuit vigorously and does not expect that the lawsuit will have a material effect on its financial position. I wonder who? Quote:NEW YORK, March 24, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Judy Caron, Ph.D., as Vice President of Drug Development. On the website 'meet our team' Dr Caron is not featured... nor is the VP of Drug Development position featured Not drawing any conclusions.